ZGN-1061
ZGN-1061 is an experimental drug that was developed by Zafgen for treatment of obesity and type 2 diabetes.
≈ 1 min read
ZGN-1061. encyclopegia.org, snapshot enwiki-001367491505. /a/zgn-1061
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
ZGN-1061 is an experimental drug that was developed by Zafgen for treatment of obesity and type 2 diabetes. It has a similar mechanism of action as the discontinued drug Beloranib but was considered safer; however, its development was also halted because of safety concerns.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1367491505 under CC BY-SA 4.0; modifications have been made.